openPR Logo
Press release

Autoimmune Disease Diagnostics Market: Rise in Autoimmune Diseases, alongside Growing Awareness about Them, Stokes Market

08-28-2018 02:43 PM CET | Health & Medicine

Press release from: Transparency Market Research

Autoimmune Disease Diagnostics Market: Rise in Autoimmune

Global Autoimmune Disease Diagnostics Market: Snapshot

The global autoimmune disease diagnostics market is expected to witness a modest growth in the coming years on account of the growing incidences of autoimmune diseases among people worldwide. Efficient autoimmune disease diagnostics has become absolutely essential to tackle this issue. Governments across nations are also increasing their spending towards healthcare in light of these growing incidences of autoimmune diseases. This has also resulted in the research and development of novel diagnostics in order to prevent the spread of autoimmune diseases.

Obtain Report Details @

Technological advancements in the medicals sector are also fueling the market’s growth. Between 2015 and 2023, the global autoimmune diseases diagnostics market is expected to exhibit a CAGR of 3.8%. The global autoimmune disease diagnostics market is likely to reach US$17.06 bn by 2023. The stiff price competition among players is expected to impact the growth of the market in a negative way.

North America to Continue to Lead in the Autoimmune Disease Diagnostics Market

By geography, North America is expected to lead in the autoimmune disease diagnostics market with the U.S. and Canada contributing the most to the market in the region. These countries have sophisticated healthcare infrastructure and laboratories with advanced techniques. There also exists high level of awareness regarding various medical procedures. The increased healthcare expenditure in the region will also be a contributing factor to the growth of the market in region.

Request for Sample Copy of Report @

Asia Pacific is also expected to witness a rapid growth in the autoimmune disease diagnostics market on account of high demand from countries such as Malaysia, Australia, India, Japan, and China. Advancements in diagnostics devices will push the Asia Pacific autoimmune disease diagnostics market towards witnessing a CAGR of 4.3% between 2015 and 2023.

High Occurrence of Rheumatoid Arthritis to Drive Autoimmune Disease Diagnostics Market

Autoimmune diseases such as Graves’ disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and type1 diabetes are prevalent commonly. Of these, the most prevalent of all diseases is rheumatoid arthritis, which can occur to people falling under any age group. The rheumatoid arthritis segment is estimated to be worth US$4.6 bn by the end of 2022. The growing geriatric population and improved diagnosis of rheumatoid arthritis at improved laboratories will drive the segment towards growth in the coming year. Apart from rheumatoid arthritis, the type 1 diabetes segment is expected to show a healthy growth and exhibit a CAGR of 3.7% between 2015 and 2023.

Request Report Brochure @

Unavailability of Trained Professionals to Result in Operational Challenges

There is a dearth of trained professionals in the market which will hamper the growth of this market. In addition to this, a lack of automation will also pose a challenge and hamper the operations in clinical laboratories. Further, the threat of new entrants, mostly local players, will cause leading players to cut down their prices. Slashing down the prices of diagnostic devices so as to stay in the market and remain competitive is projected to have an adverse impact on the global autoimmune disease diagnostics market.

However, on the plus side, the market for autoimmune disease diagnostics is expected to find new opportunities for growth as leading players will leverage the untapped markets in emerging nations and capitalize on them. Players are also expected to concentrate on replacing traditional technologies with latest ones and automate the laboratories. This will help the market to grow. Additionally, the introduction of novel technologies will create promising growth for the market.

Popular Research Reports by TMR -

Bioprocess Technology Market:

Microfluidics Market:

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmune Disease Diagnostics Market: Rise in Autoimmune Diseases, alongside Growing Awareness about Them, Stokes Market here

News-ID: 1206724 • Views: 308

More Releases from Transparency Market Research

Ambient Food Packaging Market to Register Substantial Expansion in Next 5 Years …
Ambient food packaging refers to packing a food product in pasteurised and sterilized packs to increase its shelf life. Ambient food packing has become a trend in the food packaging industry and ambient food products are preferred by majority of the consumers over others. Increasing demand for having more empty space in chill cabinets calls for the adoption of the food packaging methods that can offer a better shelf life
Horizontal Fan Coil Market is set to Garner Staggering Revenues by 2027 - TMR
Global Fan Coil Unit Market: Overview According to a new market report pertaining to the global fan coil unit market published by Transparency Market Research the global fan coil unit market is anticipated to reach volume of 11,378.2 thousand units by 2027. The fan coil unit market is projected to expand at a CAGR of 3.6 % from 2019 to 2027 in terms of sale. Growth of the fan coil unit
RTC IC Market – Opportunities in Key Application Sectors by 2029
Global Real-time Clock (RTC) IC Market: Introduction Transparency Market Research delivers key insights on the global real-time clock (RTC) IC market. In terms of revenue, the global real-time clock IC market is estimated to expand at a CAGR of ~4% during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in its report on the global real-time clock IC market. A real-time clock IC is a
Healthcare Packaging Market: Explore Top Factors that Will Boost the Global Mark …
Healthcare Packaging Market: Introduction The latest report published by Transparency Market Research on the global healthcare packaging market, includes global industry analysis, share, size, growth trends and forecast for 2021-2029. The current value of the global healthcare packaging market is US$ 100 Bn and is anticipated to expand to US$ 155 Bn by the year 2029. Growth of the pharmaceutical industry and high demand for medicinal supplies & drugs have created

All 5 Releases

More Releases for Autoimmune

Autoimmune Disease Diagnostics Market - Forecast to 2026
The findings reviewed by GME stated that the Global Autoimmune Disease Diagnostics Market would grow at a CAGR value of 8.9 percent from 2021 to 2026. Today, the advancing technology & automation, increasing awareness about risks and implications of autoimmune disease if left undiagnosed & untreated, and the awareness about the benefits of various diagnostics available are accelerating growth in the market. Also, there has been an exponential increase
Autoimmune Disease Diagnostics Market: Growing Awareness among People about Auto …
According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market. Read Report Overview - To reduce effects of such hindrances, the new entrants are
Autoimmune Treatment Market North America Leads the Global Autoimmune Treatment …
The global autoimmune treatment market is growing significantly due to increasing incidences of autoimmune diseases, up surging healthcare expenditure, and advancements in the technologies for the development of autoimmune diseases therapeutics. Autoimmune diseases are chronic in nature and do not have permanent treatment. This creates ample growth opportunity for the autoimmune treatment market, to grow at a considerable rate in the coming years. The advanced research and development facilities, and
Autoimmune Disease Diagnostics Market Growth Analysis 2023
Despite its vendor landscape being highly consolidated, intense rivalry prevails among key players in The Global Autoimmune Disease Diagnostics Market. According to Transparency Market Research (TMR), the top four companies held over 50% of the global autoimmune disease diagnostics market in 2014. Among the leading enterprises, F. Hoffmann-La Roche Ltd. held the dominant share of over 17% in the market in the same year. In response to the increasing demand for
Global Autoimmune Treatment Market Research Report 2017
Global Autoimmune Treatment Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020. The research report on global Autoimmune Treatment market offers an in-depth analysis, presenting insights into the key growth factors, which are estimated to encourage growth of the global market. In addition, the research study throws light on the drivers, barriers, latest opportunities, current trends, and the technological developments
Autoantibody Diagnostics in Autoimmune Liver Diseases
ORGENTEC Diagnostika ( has developed four new laboratory tests for the diagnosis of autoimmune liver diseases. These tests are now on the market. They are based on ELISA technology and were specifically developed for fully automated analysis with Alegria®. The new tests systems, called Anti-Sp100, Anti-gp210, Anti-LKM-1, and Anti-SLA, reliably detect specific autoantibodies that are characteristic of various autoimmune liver diseases. The tests thus also allow for reliable differentiation between these